Antimicrobials in urogenital infections

被引:29
|
作者
Wagenlehner, Florian M. E. [1 ]
Wullt, Bjoern [2 ]
Perletti, Gianpaolo [3 ]
机构
[1] Univ Giessen, Dept Urol Pediat Urol & Androl, D-35385 Giessen, Germany
[2] Skane Univ Hosp, Dept Urol, Malmo, Sweden
[3] Univ Insubria Busto Arsizio, Lab Tossicol & Farmacol, Dipartimento Biol Strutturale & Funz, Varese, Italy
关键词
Urinary tract infection; Male genital infection; Antibiotic treatment; Antimicrobial substances; URINARY-TRACT-INFECTIONS; GRAM-NEGATIVE BACILLI; PHARMACOKINETIC PROPERTIES; ANTIBACTERIAL ACTIVITY; HOSPITALIZED-PATIENTS; SURVEILLANCE PROGRAM; TRIMETHOPRIM-SULFAMETHOXAZOLE; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; PROSTATIC FLUID;
D O I
10.1016/j.ijantimicag.2011.09.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Urinary tract infections (UTIs) and male genital infections are amongst the most prevalent infections. A prudent antibiotic policy therefore has a large impact on society. The clinical classification in uncomplicated cystitis, uncomplicated pyelonephritis, complicated UTI and genital infections is useful, also for the right choice of antibiotic treatment. In this regard pharmacokinetic and pharmacodynamic aspects have to be considered. Nowadays in uncomplicated cystitis antibiotics exclusively reserved for this indication are preferred, such as fosfomycin trometamol, nitrofurantoin and pivmecillinam, in order to reduce antibiotic pressure in this extremely frequent entity. In complicated UTI a broad bacterial spectrum has to be considered. Different antibiotic substances should be used for treatment, such as penicillins, with beta-lactamase inhibitors, cephalosporins or carbapenems, fluoroquinolones, aminoglycosides or cotrimoxazole, if tested susceptible. For genital infections the pharmacokinetic properties of the antibiotics should especially be considered, such as in prostatitis, where mainly fluoroquinolones and macrolides show sufficient pharmacokinetic parameters for treatment of bacterial infections. Furthermore in genital infections fastidious organisms, such as Chlamydia or Mycoplasma spp. have to be considered with respect to their antimicrobial susceptibility. (C) 2011 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [21] SGLT2 Inhibitors and the Risk of Urogenital Infections: A Concise Review
    Confederat, Luminita-Georgeta
    Dragostin, Oana-Maria
    Condurache, Mihaela-Iustina
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
  • [22] Urinary Tract Infections
    Wang, Alina
    Nizran, Parminder
    Malone, Michael A.
    Riley, Timothy
    PRIMARY CARE, 2013, 40 (03): : 687 - +
  • [23] Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections
    Kulchavenya, Ekaterina
    Cherednichenko, Andrey
    THERAPEUTIC ADVANCES IN UROLOGY, 2018, 10 (03) : 95 - 101
  • [24] The Role of Lactobacillus Probiotics in the Treatment or Prevention of Urogenital Infections - A Systematic Review
    Abad, C. L.
    Safdar, N.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (03) : 243 - 252
  • [25] Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
    Vazquez, Roberto
    Garcia, Ernesto
    Garcia, Pedro
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [26] Timely empiric antimicrobials are associated with faster microbiologic clearance in preterm neonates with late-onset bloodstream infections
    Natarajan, Girija
    Monday, Lea
    Scheer, Terri
    Lulic-Botica, Mirjana
    ACTA PAEDIATRICA, 2014, 103 (10) : E418 - E423
  • [27] PepBiotics, novel cathelicidin-inspired antimicrobials to fight pulmonary bacterial infections
    van Eijk, Martin
    van Dijk, Albert
    van Der Ent, Cornelis K.
    Arets, Hubertus G. M.
    Breukink, Eefjan
    van Os, Nico
    Adrichem, Roy
    van Der Water, Sven
    Gomez, Rita Lino
    Kristensen, Maartje
    Hessing, Martin
    Jekhmane, Shehrazade
    Weingarth, Markus
    Veldhuizen, Ruud A. W.
    Veldhuizen, Edwin J. A.
    Haagsman, Henk P.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2021, 1865 (09):
  • [28] Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
    Lam, P. L.
    Lee, K. K. H.
    Wong, R. S. M.
    Cheng, G. Y. M.
    Bian, Z. X.
    Chui, C. H.
    Gambari, R.
    CRITICAL REVIEWS IN MICROBIOLOGY, 2018, 44 (01) : 40 - 78
  • [29] NANOTECHNOLOGY APPLICATIONS OF ANTIMICROBIALS
    Tan, Emir
    Ozyaral, Oguz
    Baktir, Gul
    GEOCONFERENCE ON NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE FUTURE, 2013, : 45 - 55
  • [30] Interconnected microbiomes-insights and innovations in female urogenital health
    Al, Kait F.
    Parris, Josh
    Engelbrecht, Kathleen
    Reid, Gregor
    Burton, Jeremy P.
    FEBS JOURNAL, 2024,